New Delhi: New research revealed that, consuming zinc acetate lozenges may raise the rate of recovery from the common cold by three fold. The analysis of three randomised controlled trials originate that on the fifth day, 70 per cent of the patients who took zinc lozenges had recovered contrast with 27 per cen of the placebo patients.
Harri Hemila from the University of Helsinki in Finland has also conveyed that, strong evidence of efficacy and the low risk of adverse effects, common cold patients may already be encouraged to try zinc acetate lozenges not more than 100 mg of elemental zinc per day for treating their colds. The researchers has also conveyed that, the effect of zinc acetate lozenges was not modified by age, sex, race, allergy, smoking, or baseline common cold severity.
The three-fold augment in the recovery rate from common cold may be widely applicable. Whereas some zinc lozenges have an unpleasant taste, the zinc acetate lozenges used in these three randomized trials did not suffer from such a difficulty. The dose of zinc in the three studies was between 80 and 92 milligrammes (mg) per day.
Such doses are significantly superior than the suggested every day zinc intake in the US, which is 11 mg/day for men and 8 mg/day for women. Researchers has also further conveyed adding that, though, unrelated to the common cold, zinc has been administered in doses of 100 to 150 mg/day to patients for months with few adverse effects.